Literature DB >> 28300523

Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.

Guoyang Zhang1,2, Ping Zhang3, Hongyun Liu1,2, Xiaoyan Liu1,2, Shuangfeng Xie1,2, Xiuju Wang1,2, Yudan Wu1,2, Jianxing Chang2,4, Liping Ma1,2.   

Abstract

OBJECTIVES: The improved passive immune thrombocytopenia (ITP) mouse model has been extensively utilized for the study of ITP. However, how closely this model matches the human inflammation state and immune background is unclear. Our study aimed to explore the profile of Th cytokines and Th17/Treg cells in the model.
METHODS: We induced the ITP mouse model by dose-escalation injection of MWReg30. The serum levels of cytokines (IFN-γ, IL-2, IL-4, IL-10, IL-17A, and TGF-β1) were measured by enzyme-linked immunosorbent assay and the frequency of Th17 and Treg cells was measured by flow cytometry. The mRNA expression of Foxp3 and RORrt was measured by real-time PCR.
RESULTS: The serum levels of cytokines IFN-γ, TGF-β1, IL-4, and IL-10 were significantly lower in ITP mice. The secretion of serum proinflammatory cytokines IL-2 and IL-17A and the percentage of Th17 cells showed no statistically significant increase. In ITP mice the frequency of Treg cells and mRNA expression of Foxp3 was significantly lower in splenocytes.
CONCLUSION: Our data suggest that the improved passive ITP mouse model does not mimic the autoimmune inflammatory process of human ITP. Compared with human ITP, this model has a similar change in frequency of Treg cells, which may directly or indirectly result from antibody-mediated platelet destruction due to attenuated release of TGF-β.

Entities:  

Keywords:  Immune thrombocytopenia; Th cytokines; Th17; Treg; mouse model

Mesh:

Substances:

Year:  2017        PMID: 28300523     DOI: 10.1080/10245332.2017.1301040

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  3 in total

1.  Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center.

Authors:  Hao Gu; Zhenping Chen; Xiaodong Shi; Hong Cui; Xuanguang Qin; Huimin Hu; Jingyao Ma; Lingling Fu; Jie Ma; Tianyou Wang; Runhui Wu
Journal:  Eur J Pediatr       Date:  2021-05-27       Impact factor: 3.183

2.  Increased Proportion of Dual-Positive Th2-Th17 Cells Promotes a More Severe Subtype of Asthma.

Authors:  Wenjin Sun; Yu Yuan; Lulu Qiu; Qingping Zeng; Jingsi Jia; Xudong Xiang; Aijun Jia; Libing Ma; Shaokun Liu; Bing Xiao
Journal:  Can Respir J       Date:  2021-08-05       Impact factor: 2.409

Review 3.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.